Skip to content

Clinical trials

Completed Retinal Vein Occlusion trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Status: Completed Country / region: United States Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20044
20052
20065
20071
20093
20108
20115
20126
20133
20145
20154
20162
20172
20194
20203
20213
20223
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan6
National Eye Institute (NEI)5
Barnes Retina Institute3
Novartis Pharmaceuticals3
Peter A Campochiaro, MD3
Regeneron Pharmaceuticals3
The Emmes Company, LLC3
Wills Eye3
California Retina Consultants2
Clearside Biomedical, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion70
Macular Edema36
Macular Degeneration17
Diabetic Retinopathy12
Retinal Diseases5
Vision Disorders4
Wet Macular Degeneration4
Geographic Atrophy3
Uveitis3
Choroidal Neovascularization2

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.